Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaw-Town Lin

Showing results (311-320 of 327) with videos related to

Pageof 33
Sort By:
The American Journal of Gastroenterology|May 22, 2024
Bleeding Risk of Cold Versus Hot Snare Polypectomy for Pedunculated Colorectal Polyps Measuring 10 mm or Less: Subgroup Analysis of a Large Randomized Controlled TrialCheng-Hao Tseng, Li-Chun Chang, Jia-Ling Wu, et al.
Nature Cancer|January 24, 2024
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapyYu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, et al.
Lancet (London, England)|November 20, 2012
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Mei-Jyh Chen, et al.
Helicobacter|July 18, 2022
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysisMei-Jyh Chen, Ming-Jong Bair, Po-Yueh Chen, et al.
Gut|August 15, 2020
Mass eradication of <i>Helicobacter pylori</i> to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu IslandsTsung-Hsien Chiang, Wei-Jung Chang, Sam Li-Sheng Chen, et al.
The Lancet. Infectious Diseases|September 28, 2019
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Chih-Min Chang, et al.
The American Journal of Gastroenterology|February 3, 2016
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized TrialJyh-Ming Liou, Ming-Jong Bair, Chieh-Chang Chen, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2023
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trialsMei-Jyh Chen, Po-Yueh Chen, Yu-Jen Fang, et al.
Endoscopy|October 13, 2025
A rural-to-center artificial intelligence model for diagnosing Helicobacter pylori infection and premalignant gastric conditions using endoscopy images captured in routine practiceTsung-Hsien Chiang, Yen-Ning Hsu, Min-Han Chen, et al.
Gut|September 5, 2015
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of <i>Helicobacter pylori</i> in the community and hospital populations: a randomised trialJyh-Ming Liou, Chieh-Chang Chen, Chi-Yang Chang, et al.
Pageof 33

Showing results (311-320 of 327) with videos related to

Sort By:
Pageof 33
The American Journal of Gastroenterology|May 22, 2024
Bleeding Risk of Cold Versus Hot Snare Polypectomy for Pedunculated Colorectal Polyps Measuring 10 mm or Less: Subgroup Analysis of a Large Randomized Controlled TrialCheng-Hao Tseng, Li-Chun Chang, Jia-Ling Wu, et al.
Nature Cancer|January 24, 2024
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapyYu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, et al.
Lancet (London, England)|November 20, 2012
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Mei-Jyh Chen, et al.
Helicobacter|July 18, 2022
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysisMei-Jyh Chen, Ming-Jong Bair, Po-Yueh Chen, et al.
Gut|August 15, 2020
Mass eradication of <i>Helicobacter pylori</i> to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu IslandsTsung-Hsien Chiang, Wei-Jung Chang, Sam Li-Sheng Chen, et al.
The Lancet. Infectious Diseases|September 28, 2019
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Chih-Min Chang, et al.
The American Journal of Gastroenterology|February 3, 2016
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized TrialJyh-Ming Liou, Ming-Jong Bair, Chieh-Chang Chen, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2023
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trialsMei-Jyh Chen, Po-Yueh Chen, Yu-Jen Fang, et al.
Endoscopy|October 13, 2025
A rural-to-center artificial intelligence model for diagnosing Helicobacter pylori infection and premalignant gastric conditions using endoscopy images captured in routine practiceTsung-Hsien Chiang, Yen-Ning Hsu, Min-Han Chen, et al.
Gut|September 5, 2015
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of <i>Helicobacter pylori</i> in the community and hospital populations: a randomised trialJyh-Ming Liou, Chieh-Chang Chen, Chi-Yang Chang, et al.
Pageof 33